BOUNDLESS SCIENCE INC. — Department of Defense SBIR Phase II: BOUNDLESS DHA SBIR PHASE II MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR "ARDS OXYGENATIO
BOUNDLESS SCIENCE INC. — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- At $2,998,822, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Boundless Science Inc. won a $3 million Phase II SBIR contract from the Defense Health Agency to develop an ARDS Oxygenation Device. The project focuses on medical research and development of a device to treat acute respiratory distress syndrome.
- Amount
- $2,998,822
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- NC
- Period
- 2024-05-06 → 2027-04-09
Technology domains
Description
BOUNDLESS DHA SBIR PHASE II MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR "ARDS OXYGENATION DEVICE (AOD)"